Peoples Financial Services Corp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-31
| Closed | -$5.7K | – | 277 |
|
|
2025
Q4 | $5.7K | Hold |
31
| – | – | ﹤0.01% | 248 |
|
|
2025
Q3 | $4.76K | Hold |
31
| – | – | ﹤0.01% | 248 |
|
|
2025
Q2 | $4.33K | Sell |
31
-4
| -11% | -$561 | ﹤0.01% | 241 |
|
|
2025
Q1 | $5.14K | Sell |
35
-4
| -10% | -$579 | ﹤0.01% | 238 |
|
|
2024
Q4 | $5.04K | Hold |
39
| – | – | ﹤0.01% | 238 |
|
|
2024
Q3 | $6K | Hold |
39
| – | – | ﹤0.01% | 231 |
|
|
2024
Q2 | $6K | Sell |
39
-11
| -22% | -$1.66K | ﹤0.01% | 235 |
|
|
2024
Q1 | $6.78K | Hold |
50
| – | – | ﹤0.01% | 225 |
|
|
2023
Q4 | $6.74K | Hold |
50
| – | – | ﹤0.01% | 227 |
|
|
2023
Q3 | $6.77K | Hold |
50
| – | – | ﹤0.01% | 229 |
|
|
2023
Q2 | $7.16K | Hold |
50
| – | – | ﹤0.01% | 229 |
|
|
2023
Q1 | $6.94K | Hold |
50
| – | – | ﹤0.01% | 232 |
|
|
2022
Q4 | $6.78K | Hold |
50
| – | – | ﹤0.01% | 233 |
|
|
2022
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 244 |
|
|
2022
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 240 |
|
|
2022
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 247 |
|
|
2021
Q4 | $6K | Sell |
50
-25
| -33% | -$2.94K | ﹤0.01% | 239 |
|
|
2021
Q3 | $9K | Hold |
75
| – | – | ﹤0.01% | 232 |
|
|
2021
Q2 | $9K | Hold |
75
| – | – | ﹤0.01% | 237 |
|
|
2021
Q1 | $7K | Hold |
75
| – | – | ﹤0.01% | 239 |
|
|
2020
Q4 | $7K | Hold |
75
| – | – | ﹤0.01% | 237 |
|
|
2020
Q3 | $8K | Hold |
75
| – | – | ﹤0.01% | 214 |
|
|
2020
Q2 | $8K | Hold |
75
| – | – | ﹤0.01% | 222 |
|
|
2020
Q1 | $7K | Hold |
75
| – | – | ﹤0.01% | 230 |
|
|
2019
Q4 | $7K | Hold |
75
| – | – | ﹤0.01% | 246 |
|
|
2019
Q3 | $7K | Hold |
75
| – | – | ﹤0.01% | 260 |
|
|
2019
Q2 | $6K | Hold |
75
| – | – | ﹤0.01% | 271 |
|
|
2019
Q1 | $6K | Sell |
75
-38
| -34% | -$3K | ﹤0.01% | 264 |
|
|
2018
Q4 | $9K | Hold |
113
| – | – | 0.01% | 220 |
|
|
2018
Q3 | $9K | Hold |
113
| – | – | ﹤0.01% | 233 |
|
|
2018
Q2 | $8K | Hold |
113
| – | – | ﹤0.01% | 231 |
|
|
2018
Q1 | $8K | Hold |
113
| – | – | ﹤0.01% | 240 |
|
|
2017
Q4 | $8K | Hold |
113
| – | – | ﹤0.01% | 238 |
|
|
2017
Q3 | $8K | Hold |
113
| – | – | ﹤0.01% | 233 |
|
|
2017
Q2 | $8K | Hold |
113
| – | – | ﹤0.01% | 232 |
|
|
2017
Q1 | $7K | Buy |
+113
| New | +$6.58K | ﹤0.01% | 243 |
|
|
2016
Q4 | – | Sell |
-113
| Closed | -$7K | – | 302 |
|
|
2016
Q3 | $7K | Buy |
+113
| New | +$7.39K | ﹤0.01% | 231 |
|
Other funds holding AZN
IA
VCM
VAM
Peoples Financial Services Corp's AZN Position: Q1 2026 in Review
Peoples Financial Services Corp sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 31 shares — an estimated $5.7K sold.
Peoples Financial Services Corp first reported a position in AZN in Q3 2016 and held it in 37 quarters. The position peaked at $9K in Q3 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Peoples Financial Services Corp reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Peoples Financial Services Corp sold 31 AstraZeneca shares in Q1 2026, an estimated $5.7K.
- Peoples Financial Services Corp first reported a position in AstraZeneca in Q3 2016 and held it in 37 quarters.
- Peoples Financial Services Corp's AstraZeneca position peaked at $9K in Q3 2021.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Peoples Financial Services Corp's 13F filing for Q1 2026, filed 20 Apr 2026.